Giant Prolactinomas: Outcomes of Multimodal Treatments for 42 Cases with Long-Term Follow-Up.

@article{Lv2019GiantPO,
  title={Giant Prolactinomas: Outcomes of Multimodal Treatments for 42 Cases with Long-Term Follow-Up.},
  author={Liang Lv and Yu Cheng Hu and Senlin Yin and Peizhi Zhou and Yuan Yang and Weichao Ma and Shizhen Zhang and Xiujie Wang and Shu Jiang},
  journal={Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association},
  year={2019},
  volume={127 5},
  pages={
          295-302
        }
}
Giant prolactinomas represent a rare entity of pituitary tumors so that the management of these patients is still a prevalent challenge at present. Paying special attention to the treatment strategy and outcomes, we presented a large series of 42 cases looking forward to share our understanding and experience in management of these patients. Male patients accounted for 71.4% of this series and were relatively younger (35.70±2.42 vs. 52.00±3.55 years, p=0.0011) and harbored bigger tumors (14.57… CONTINUE READING
BETA

Similar Papers